𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carrier-mediated uptake of pravastatin by rat hepatocytes in primary culture

✍ Scribed by Toru komai; Eiji Shigehara; Taro Tokui; Teiichiro Koga; Michi Ishigami; Chitose Kuroiwa; Seikoh Horiuchi


Book ID
115782721
Publisher
Elsevier Science
Year
1992
Tongue
English
Weight
458 KB
Volume
43
Category
Article
ISSN
0006-2952

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Inhibition of carrier-mediated uptake of
✍ Tomomi Iwakiri; Manabu Okumura; Muneaki Hidaka; Yuki Kumagai; Emi Ichihara; Yohe πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 234 KB

## Abstract Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy‐dependent manner because epirubicin is a substrate for P‐glycoprotein (P‐gp). However, this study investigated the details of

TISSUE-SELECTIVE UPTAKE OF PRAVASTATIN I
✍ Masayo Yamazaki; Taro Tokui; Michi Ishigami; Yuichi Sugiyama πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 780 KB

Previously we demonstrated that a hydrophilic HMG-CoA reductase inhibitor, pravastatin, was actively taken up by the liver via the 'multispecific anion transporter' using isolated rat hepatocytes (M. Yamazaki, H. Suzuki, M. Hanano, T. Tokui, T. Komai, and Y. Sugiyama, Am. J. Physiol., 264, G36-G44 (